CAT overturns CMA’s abuse finding in Pfizer/Flynn excessive pricing case

The Competition Appeal Tribunal has set aside the CMA’s findings on abuse in the Pfizer/Flynn excessive pricing case. The CAT has provisionally decided to remit the issue to the CMA for reconsideration, although the CMA has indicated that it is considering appealing the decision. Click here.

Government amends merger control rules for military and dual-use technology, computing hardware and quantum technology sectors

The Government has amended the UK merger control rules to increase the ability of ministers to intervene on national security grounds in relation to mergers involving the military and dual-use technology, computing hardware and quantum technology sectors. Click here.

European Commission confirms dawn raids in the styrene monomer purchasing sector

The European Commission has confirmed that on 5 June 2018 it carried out unannounced inspections of companies active in styrene monomer purchasing in several Member States. The Commission has concerns that the inspected companies may have violated Article 101 of the Treaty on the Functioning of the European Union. The Commission officials were accompanied by their counterparts from the relevant national competition authorities. Click here.

EU

Mergers

  • The European Commission has opened an in-depth Phase 2 investigation to assess the proposed acquisition of Tele2 NL by T-Mobile NL under the EU Merger Regulation. The Commission is concerned that the merger could lead to higher prices, and reduce choice and innovation for mobile customers in the Netherlands. Click here.

UK

CMA

  • The CMA is proposing to refer a merger between two towbar companies for a detailed phase 2 investigation, unless the parties offer suitable undertakings. Click here.
  • The CMA is proposing to refer the proposed merger between data companies Nielsen and Ebiquity's advertising intelligence division for a detailed Phase 2 investigation, unless the parties offer suitable undertakings. Click here.